IPO - Alligator Bioscience

Disclaimer

The following pages contain information relating to an initial public offering and listing of securities issued by Alligator Bioscience AB (the “Company”). This information may not be accessed by residents of certain countries based on applicable securities law regulations.

NOT FOR DISTRUBUTION, DIRECLY OR INDIRECLY, IN THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, JAPAN OR ANY OTHER JURISTDICTION WHERE TO DO SO WOULD BE PROHIBITED BY APPLICABLE LAW.

The following pages include information pertaining to an initial public offering and listing of securities issued by the Company.
This website and the information contained herein are not intended for, and may not be accessed by, or distributed or disseminated to, persons resident or physically present in the United States of America (including its territories and possessions), any state of the United States and the District of Columbia (the “United States”), Australia, Canada or Japan, and do not constitute an offer to sell or the solicitation of an offer to purchase or acquire, any securities of the Company in the United States, Australia, Canada, Japan or in any other jurisdiction in which such offer or solicitation would be unlawful prior to registration or qualification under the securities laws of such jurisdiction. The securities of the Company referred to on this website have not been and will not be registered under the U.S. Securities Act of 1933, as amended (the “U.S. Securities Act”), and may not be offered or sold in the United States absent registration or an exemption from registration under the U.S. Securities Act.

All persons residing outside of the United States, Australia, Canada and Japan who wish to access the documents contained on this website should first ensure that they are not subject to local laws or regulations that prohibit or restrict their right to access this website, or require registration or approval for any acquisition of securities by them. The Company assumes no responsibility if there is a violation of applicable law and regulations by any person.

If you are not permitted to view materials on this website or are in any doubt as to whether you are permitted to view these materials, please exit this website.

Access to electronic versions of these materials is being made available on this website by the Company in good faith and for information purposes only.

By clicking “Yes” you confirm and certify that:
You are not a resident of or physically present in the United States, Australia, Canada or Japan or any other restricted jurisdiction and are not a U.S. person (as defined in Regulation S under the U.S. Securities Act); and you are either: (a) a resident of, or physically present in, Sweden; (b) if resident or physically present in a Member State of the European Economic Area other than Sweden, a qualified investor as defined in Directive 2003/71/EC (as amended); or (c) otherwise authorised to access this information pursuant to applicable laws or regulations.

YES or NO

Price interval	32,50 SEK per share
Application period for the public in Sweden	15 November - 22 November 2016
Application period for institutional investors	15 November - 22 November 2016
First day of trading	23 November 2016
Settlement date	25 November 2016

Alligator Bioscience

Listing of Alligator Bioscience AB on Nasdaq Stockholm

Pressreleases

The offering in summary

Prospectus

Disclaimer